Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds (CMS)
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Sponsor: Arteriocyte, Inc.
Terminated
This trial was terminated. No reason was provided.
Other Diabetic Foot Ulcers trials with similar outcome
Listed as NCT02071979, this NA trial focuses on Diabetic Foot Ulcers and Pressure Ulcers and remains terminated or withdrawn. Sponsored by Arteriocyte, Inc., it has been updated 8 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Feb 2018 — Jun 2018 [monthly]
Terminated NA
Status: Recruiting → Terminated
▶ Show 3 earlier versions
-
May 2017 — Feb 2018 [monthly]
Recruiting NA
-
Feb 2017 — May 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Arteriocyte, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .